Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institutul De Medicina Si Farmacie, Bucuresti, RofiledCriticalInstitutul De Medicina Si Farmacie, Bucuresti, Ro
Priority to RO141512ApriorityCriticalpatent/RO102777B1/ro
Publication of RO102777A2publicationCriticalpatent/RO102777A2/ro
Publication of RO102777B1publicationCriticalpatent/RO102777B1/ro
Pharmaceutical formulation containing an insulin derivative modified with a base, with an isoelectric point between 5.8 - 8.5, and with a zinc ion content of from 2mug - 200mug of zinc/iu
Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7,17)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn -3-one
Tricyklisk 5-(3-chlor-6-methyl-5,5-dioxo-6,11-dihydro-dibenzo-(c,f)-(1,2)-thiazepin-11-yl)-amino-pentansyrederivat, fremgangsmaade til fremstilling deraf og farmaceutiske midler indeholdende dem